Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 9/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.37 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.37 |
| ▸ | CCR2 | P41597 | 1/20 | 0.37 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.37 |
| ▸ | BLM | P54132 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CHKA | P35790 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | HRH1 | P35367 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3769647 | 1.00 | CXCR4 (0.42) | CXCR4SMN1; SMN2ALDH1A1TDP1MEN1 | |
| SCHEMBL2918689 | 0.97 | CXCR4 (0.41) | CXCR4SMN1; SMN2ALDH1A1TDP1MEN1 | |
| SCHEMBL2918481 | 0.97 | CXCR4 (0.41) | CXCR4SMN1; SMN2ALDH1A1TDP1MEN1 | |
| SCHEMBL29095229 | 0.94 | CXCR4 (0.53) | CXCR4SMN1; SMN2ALDH1A1TDP1MEN1 | |
| SCHEMBL2914797 | 0.94 | ALDH1A1 (0.44) | CXCR4SMN1; SMN2ALDH1A1TDP1MEN1 | |
| SCHEMBL2010175 | 0.90 | CA2 (0.36) | CXCR4SMN1; SMN2ALDH1A1TDP1CA2 | |
| SCHEMBL1258379 | 0.90 | CA2 (0.42) | CXCR4SMN1; SMN2ALDH1A1TDP1CA2 | |
| SCHEMBL5030028 | 0.89 | ALDH1A1 (0.47) | CXCR4SMN1; SMN2ALDH1A1TDP1MEN1 | |
| SCHEMBL28441176 | 0.88 | CXCR4 (0.44) | CXCR4SMN1; SMN2ALDH1A1TDP1MEN1 | |
| SCHEMBL336574 | 0.87 | CA2 (0.46) | CXCR4SMN1; SMN2ALDH1A1TDP1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250066398-A1 | RECEPTOR INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF | BEIJING TIDE PHARMACEUTICAL CO LTD (CN) | 2025-02-27 | — | — | US | disclosed |
| US-12180243-B2 | Receptor inhibitor, pharmaceutical composition comprising same, and use thereof | BEIJING TIDE PHARMACEUTICAL CO., LTD. (CN) | 2024-12-31 | — | — | US | disclosed |
| EP-3770148-B1 | RECEPTOR INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF | BEIJING TIDE PHARMACEUTICAL CO LTD (CN) | 2024-10-02 | — | — | EP | disclosed |
| US-20230106958-A1 | RECEPTOR INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF | BEIJING TIDE PHARMACEUTICAL CO LTD (CN) | 2023-04-06 | — | — | US | disclosed |
| US-11453690-B2 | Receptor inhibitor, pharmaceutical composition comprising same, and use thereof | BEIJING TIDE PHARMACEUTICAL CO., LTD. (CN) | 2022-09-27 | — | — | US | disclosed |
| CN-103360330-A | Synthetic method for homopiperazine | LIU HUAIZHEN | 2013-10-23 | — | — | CN | disclosed |
| US-8207157-B2 | agents result in masking attractive odors from insects that normally would be receptive to the attractants by producing anosmia or hyposmia in the insects; ticks, mites, cockroaches and mosquitoes | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 2012-06-26 | — | — | US | disclosed |
| US-20110152285-A1 | PYRROLE ANTIFUNGAL AGENTS | F2G LTD (GB) | 2011-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230106958-A1 | RECEPTOR INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF | TACR1, TACR2, GPBAR1 | CXCR4 1039/4885SMN1; SMN2 4656/4885ALDH1A1 1113/4885 |
| US-11453690-B2 | Receptor inhibitor, pharmaceutical composition comprising same, and use thereof | TACR1, TACR2, GPBAR1 | CXCR4 1039/4885SMN1; SMN2 4656/4885ALDH1A1 1113/4885 |
| US-20250066398-A1 | RECEPTOR INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF | TACR1, TACR2, GPBAR1 | CXCR4 1039/4885SMN1; SMN2 4656/4885ALDH1A1 1113/4885 |
| US-20110152285-A1 | PYRROLE ANTIFUNGAL AGENTS | FOXM1, PYCR1, ARG1 | CXCR4 4447/4885SMN1; SMN2 2831/4885ALDH1A1 219/4885 |
| US-12180243-B2 | Receptor inhibitor, pharmaceutical composition comprising same, and use thereof | TACR1, TACR2, GPBAR1 | CXCR4 1039/4885SMN1; SMN2 4656/4885ALDH1A1 1113/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.